Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by PharmaJet

< Previous 1 2 Next >
PharmaJet Announces U.S. Government Award Expansion to Clinically Assess a DNA Vaccine Combined with its Systems
From PharmaJet
Via Business Wire
Needle-Free Precision Delivery Systems Boost Immune Response of DNA Vaccines: Comprehensive Scientific Literature Review
From PharmaJet
Via Business Wire
PharmaJet Partner Gennova Biopharmaceuticals Seeks Emergency Use Authorization in India for the First Needle-Free mRNA Vaccine Omicron Booster
From PharmaJet
Via Business Wire
PharmaJet Announces Clinical Results from Scancell’s COVID-19 DNA Vaccine Study Exclusively Administered with Their Needle-free Precision Delivery Systems
From PharmaJet
Via Business Wire
PharmaJet, Nigeria's National Primary Health Care Development Agency and Health-focused Consortium Launch Assessment of the PharmaJet Tropis Vaccine Delivery System
From PharmaJet
Via Business Wire
Review Highlights Growing Evidence That PharmaJet’s Precision Delivery Devices Improve Nucleic Acid Vaccine Performance
From PharmaJet
Via Business Wire
PharmaJet Partner Immunomic Therapeutics Receives FDA Fast Track Designation for pDNA Vaccine for Skin Cancer
From PharmaJet
Via Business Wire
PharmaJet Receives NIH Grant to Evaluate use of Needle-free Intradermal Delivery for HPV Immunization
From PharmaJet
Via Business Wire
PharmaJet Needle-free System Selected to Deliver Intradermal Polio Vaccine in Nigerian Campaign
From PharmaJet
Via Business Wire
On World Polio Day 2022, PharmaJet Announces $1.5 million Grant From USAID to Evaluate Use of Needle-Free Delivery in Routine Polio Immunization
From PharmaJet
Via Business Wire
PharmaJet to Present Latest Research Showing Superior Immunogenicity with Their Needle-free Systems at Five Conferences in October
From PharmaJet
Via Business Wire
PharmaJet Presents Latest Research Showing Benefits of Needle-free at Military Health System Research Symposium
From PharmaJet
Via Business Wire
WHO selects PharmaJet Needle-free Injection System for Million+ Polio Vaccination Campaign
From PharmaJet
Via Business Wire
University of Adelaide Begins Human Trial of Omicron COVID Vaccine Booster Using PharmaJet Needle-free System
From PharmaJet
Via Business Wire
PharmaJet Partner, Scancell, Announces Phase 2 Melanoma DNA Vaccine Trial will include Needle-free Delivery
From PharmaJet
Via Business Wire
PharmaJet Presents Latest Research Showing Benefits of Needle-free at mRNA-Based Therapeutics Summit
From PharmaJet
Via Business Wire
PharmaJet Partner, Nykode Therapeutics, Announces Positive Interim Results in HPV+ Cervical Cancer Phase 2 Trial
From PharmaJet
Via Business Wire
The Lancet Publication Shows Benefits of PharmaJet Needle-free delivery for World’s First Commercialized Plasmid DNA COVID-19 Vaccine
From PharmaJet
Via Business Wire
PharmaJet Partner, Institute for Molecular Medicine, Launches Clinical Trial for the First in Human Alzheimer’s DNA Vaccine
From PharmaJet
Via Business Wire
PharmaJet Announces Addition of Darin Zehrung as Chief Business Development Officer
From PharmaJet
Via Business Wire
PharmaJet Presents Partner Data Demonstrating Superior Immunogenicity With Their Needle-free Systems at World Vaccine Congress
From PharmaJet
Via Business Wire
PharmaJet Launches New Interactive Website
From PharmaJet
Via Business Wire
Video Features PharmaJet Needle-free Polio Immunization Campaign
From PharmaJet
Via Business Wire
PharmaJet Partner Immunomic Therapeutics Initiates Clinical Trial of DNA Vaccine for Skin Cancer
From PharmaJet
Via Business Wire
PharmaJet Partner Technovalia Announces Interim Results of Needle-free COVID-19 Vaccine Trial
From PharmaJet
Via Business Wire
PharmaJet CEO Featured in CEOCFO Magazine
From PharmaJet
Via Business Wire
University of Cambridge Begins COVID-19 Clinical Trial Using PharmaJet’s Needle-free System
From PharmaJet
Via Business Wire
PharmaJet partner Zydus Cadila Announces COVID-19 Vaccine Expansion Plan to Multiple Countries With Korean Firm
From PharmaJet
Via Business Wire
PharmaJet Partner Nykode Therapeutics Announces Phase 1/2 Clinical Trial With Next Generation DNA-Based COVID-19 Vaccine Candidates
From PharmaJet
Via Business Wire
PharmaJet Named Asia’s Most Innovative Vaccine Delivery System at the Vaccine World Asia Congress 2021
From PharmaJet
Via Business Wire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.